David Chiron

10PUBLICATIONS

34CO-AUTHORS

Cancer diagnosisHaematological tumoursCancer cell biologyMolecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jul 04, 2026

The alternative NF-κB RelB subunit is a novel critical sensor of lipid metabolism to promote tumor development.

|Feb 19, 2026

CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.

Candice Madiot, Céline Bellanger, Christelle Dousset

|Aug 09, 2025

MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblasts.

Chloé C Lefebvre, Philippine Giowachini, Jennifer Derrien

|Feb 06, 2025

VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target.

Ophélie Champion, Sophie Maïga, Chloé Antier

|Oct 09, 2024

Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells.

Romane Durand, Céline Bellanger, Géraldine Descamps

|Mar 29, 2024

Unraveling MCL biology to understand resistance and identify vulnerabilities.

Clémentine Sarkozy, Benoit Tessoulin, David Chiron

Pageof 2

Frequent Collaborators

5 joint publications

Catherine Pellat-Deceunynck

4 joint publications

Benoit Tessoulin

3 joint publications

Géraldine Descamps

3 joint publications

Patricia Gomez-Bougie

Agnes Moreau-Aubry

Yannick Le Bris

Romane Durand

François Guillonneau

A Hammoutene

M-C Alves-Guerra

Frequent Collaborators

5 joint publications

Catherine Pellat-Deceunynck

4 joint publications

Benoit Tessoulin

3 joint publications

Géraldine Descamps

3 joint publications

Patricia Gomez-Bougie